Article

ACR 2011: Early Aggressive Therapy in Polyarticular Juvenile Idiopathic Arthritis [VIDEO]

One of the more exciting parts of the conference has been the ability to sit in and listen to highlighted studies that are selected by the ACR. This press conference features Carol Wallace, MD, Seattle Children's Hospital and Research Institute, Seattle, WA, speaking about her study and answering questions from the audience.

One of the more exciting parts of the conference has been the ability to sit in and listen to highlighted studies that are selected by the ACR. This press conference features Carol Wallace, MD, Seattle Children's Hospital and Research Institute, Seattle, WA, speaking about her study and answering questions from the audience.

This activity is not sanctioned by, nor a part of, the American College of Rheumatology.

Related Videos
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
A. Sidney Barritt, MD | Credit: UNC School of Medicine
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
© 2024 MJH Life Sciences

All rights reserved.